The video above is from Tuesday's MarketFoolery podcast, featuring host Chris Hill and analysts Joe Magyer and Bill Mann. In this segment, the guys look at Johnson & Johnson's (NYSE: JNJ ) latest earnings report, which turned out better than expected thanks to prescription drug sales and JNJ's medical device division. They also discuss why the company's growth opportunity in China is stronger than people may think.
If you're looking for some additional ideas or insights on your quest for high-yielding stocks, The Motley Fool has compiled a special free report outlining our top nine dependable dividend-paying companies. It's called "Secure Your Future With 9 Rock-Solid Dividend Stocks," and you can access your complimentary copy today at no cost. Simply click here now to get started and discover the winners we've selected.